Cargando…
Circulating interleukin-6 and rheumatoid arthritis: A Mendelian randomization meta-analysis
Interleukin-6 (IL-6), as a pleiotropic cytokine, has been demonstrated to be closely associated with the pathogenisis of rheumatoid arthritis (RA). However, whether this association is causal or not remains unclear, because of the multifactorial role of IL-6 and related confounding factors. We aimed...
Autores principales: | Li, Bing, Xiao, Yu, Xing, Dan, Ma, Xin-long, Liu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907673/ https://www.ncbi.nlm.nih.gov/pubmed/27281095 http://dx.doi.org/10.1097/MD.0000000000003855 |
Ejemplares similares
-
The role of circulating miR-146a in patients with rheumatoid arthritis treated by Tripterygium wilfordii Hook F
por: Chen, Zhen-Zhou, et al.
Publicado: (2017) -
Biologic therapy for amyloid A amyloidosis secondary to rheumatoid arthritis treated with interleukin 6 therapy: Case report and review of literature
por: Jung, Ju-Yang, et al.
Publicado: (2021) -
Methotrexate can prevent cardiovascular events in patients with rheumatoid arthritis: An updated meta-analysis
por: Sun, Kai-jun, et al.
Publicado: (2021) -
Meta-analysis of risk factors for cardiovascular disease in patients with rheumatoid arthritis
por: Lyu, Qian, et al.
Publicado: (2023) -
Association Between Anti-TNF Therapy for Rheumatoid Arthritis and Hypertension: A Meta-Analysis of Randomized Controlled Trials
por: Zhao, Qingwei, et al.
Publicado: (2015)